1-5 of 5
Anna Lawson
Close
Sort by
Journal Articles

A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL)

Emma Seaford, Nicole Scobie, Lia Gore, Sarah Alexander, Auke Beishuizen, Birte Wistinghausen, Veronique Minard-Colin, Catherine M. Bollard, Karin Mellgren, Carl Allen, Anne Auperin, Victoria Buenger, Pamela R. Kearns, Anna Lawson, Ellie Williams, Shanna Maycock, Zahra Ahmed, Mahnoor Muzaffar, Rhianna Parsons, Lucinda Billingham, Gladstone Austin Amos Burke
Journal: Blood
Blood (2023) 142 (Supplement 1): 6247.
https://doi.org/10.1182/blood-2023-178724
Published: 2023
Journal Articles

A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma (Glo-BNHL)

Emma Seaford, Shanna Maycock, Sarah Alexander, Auke Beishuizen, Birte Wistinghausen, Veronique Minard-Colin, Charlotte Rigaud, Charles A Phillips, James B. Ford, Pamela R. Kearns, Anna Lawson, Ellie Williams, Zahra Ahmed, Mahnoor Muzaffar, Rhianna Parsons, Lia Gore, Nicole Scobie, Victoria Buenger, Carl Allen, Karin Mellgren, Catherine M. Bollard, Anne Auperin, Lucinda Billingham, Gladstone Austin Amos Burke
Journal: Blood
Blood (2023) 142 (Supplement 1): 3097.
https://doi.org/10.1182/blood-2023-178658
Published: 2023
Journal Articles

Outcomes for Children with High Risk Acute Myeloid Leukemia on the Myechild 01 International Phase III Clinical Trial

Andrew Moore, Shanna Maycock, Guy Leverger, Owen Smith, Andre Baruchel, Yves Bertrand, Phil Ancliff, Nicholas Heaney, Geoff Shenton, Arnaud Petit, Jean-Pierre Bourquin, Aimee Jackson, Anna Lawson, Persis Amrolia, Gerard Michel, Jean-Hugues Dalle, Marc Ansari, Hélène Lapillonne, Richard Dillon, Jelena Jovanovic, Christophe Roumier, Nicolas Duployez, Christine Harrison, Claire Schwab, Wendy Cuccuini, Marina Lafage-Pochitaloff, Paresh Vyas, Pierre Hirsch, Gareth Veal, Pam Kearns, Brenda Gibson
Journal: Blood
Blood (2023) 142 (Supplement 1): 730.
https://doi.org/10.1182/blood-2023-181593
Published: 2023
Journal Articles

Molecular MRD Monitoring Is Feasible in the Majority of Children with AML and Is Highly Predictive of Outcome: Results from the International MyeChild01 Study

Jelena Jovanovic, PhD, Nicola Potter, PhD, Anju Kanda, MSc, Claire Schwab, PhD, Aimee E Jackson, MSc, Richard Dillon, MA, PhD MRCP, FRCPath, Anna Lawson, BSc, Manohursingh Runglall, MSc, Paresh Vyas, MD PhD, Paul Virgo, Geoff Shenton, Nicholas Heaney, Beki James, MD, Katharine Patrick, MD, Persis J Amrolia, FRCP, FRCPath, PhD, Jean-Hugues Dalle, MD PhD, Gerard Michel, MD, Andrew S. Moore, MBBS,FRACP,PhD, Hélène Lapillonne, MD PhD, Claude Preudhomme, PharmD, PhD, Guy Leverger, MD, Owen P Smith, MD, Andre Baruchel, MD, Yves Bertrand, MD, Arnaud Petit, MD PhD, Keith Wheatley, DPhil, Pamela R. Kearns, PhDFRCPC, Christine J. Harrison, PhD FRCPath, Brenda Gibson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1393.
https://doi.org/10.1182/blood-2019-125257
Published: 2019
Journal Articles

Intensified Dosing of Gemtuzumab Ozogamicin Can be Safely Combined with Induction Chemotherapy in Children with Acute Myeloid Leukaemia (AML) and High Risk Myelodysplasia (MDS)

Brenda Gibson, MD PhD, Aimee E Houlton, BSc, MSc, Andre Baruchel, MD, Guy Leverger, MD PhD, Owen P Smith, MD, Anna Lawson, BSc, Keith Wheatley, DPhil, Pamela R. Kearns, PhD FRCPC
Journal: Blood
Blood (2018) 132 (Supplement 1): 2681.
https://doi.org/10.1182/blood-2018-99-115899
Published: 2018